IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

休市中 08-23 16:00:00 EDT

0.5350

+0.0149

+2.86%

盘后0.6000

+0.0650+12.15%

19:28 EDT

最高0.5660	最低0.5350	成交量8.18万
今开0.5580	昨收0.5201	日振幅5.96%
总市值2,503万	流通市值1,558万	总股本4,679万
成交额4.52万	换手率0.28%	流通股本2,911万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":0.535,"timestamp":1724443200000,"preClose":0.5201,"halted":0,"volume":81833,"hourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.535,"latestTime":"19:28 EDT","volume":12721,"amount":7579.1055,"timestamp":1724455721636},"delay":0,"floatShares":29112199,"shares":46786948,"eps":-0.823544,"marketStatus":"休市中","marketStatusCode":7,"change":0.0149,"latestTime":"08-23 16:00:00 EDT","open":0.558,"high":0.566,"low":0.535,"amount":45175.25871431,"amplitude":0.059604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.823544,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1605157200000,"adjPreClose":0.5201,"preHourTrading":{"tag":"盘前","latestPrice":0.55,"preClose":0.5366,"latestTime":"09:28 EDT","volume":1870,"amount":1021.002796,"timestamp":1724419695010},"postHourTrading":{"tag":"盘后","latestPrice":0.6,"preClose":0.535,"latestTime":"19:28 EDT","volume":12721,"amount":7579.1055,"timestamp":1724455721636},"volumeRatio":0.336794605812094},"requestUrl":"/m/hq/s/INAB","defaultTab":"news","newsList":[{"id":"2461833409","title":"In8Bio, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461833409","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461833409?lang=zh_cn&edition=full","pubTime":"2024-08-21 02:58","pubTimestamp":1724180320,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日02时58分，In8Bio, Inc.股票出现波动，股价快速下跌5.00%。截至发稿，该股报0.570美元/股，成交量17.9943万股，换手率0.38%，振幅9.83%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821025840971995b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821025840971995b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2460034493","title":"In8Bio, Inc.盘中异动 早盘股价大跌5.71%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460034493","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460034493?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:40","pubTimestamp":1724074822,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时40分，In8Bio, Inc.股票出现波动，股价大幅跳水5.71%。截至发稿，该股报0.660美元/股，成交量7757股，换手率0.02%，振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192140229719921d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192140229719921d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2460736024","title":"In8Bio, Inc.2024财年第二财季实现净利润-8.63百万美元，同比减少11.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736024","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736024?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910664,"startTime":"0","endTime":"0","summary":"8月18日，In8Bio, Inc.公布财报，公告显示公司2024财年第二财季净利润为-8.63百万美元，同比减少11.79%；其中营业收入为0.00美元，每股基本收益为-0.19美元。从资产负债表来看，In8Bio, Inc.总负债8.88百万美元，其中短期债务1.78百万美元，资产负债比为2.54，流动比率为2.67。机构评级：截至2024年8月18日，当前有6家机构对In8Bio, Inc.目标价做出预测，其中目标均价为7.42美元，其中最低目标价为5.00美元，最高目标价为12.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006519f3407ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006519f3407ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB"],"gpt_icon":0},{"id":"2460324064","title":"In8Bio, Inc.盘中异动 大幅上涨6.15%报0.640美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460324064","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460324064?lang=zh_cn&edition=full","pubTime":"2024-08-17 01:31","pubTimestamp":1723829507,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日01时31分，In8Bio, Inc.股票出现异动，股价快速上涨6.15%。截至发稿，该股报0.640美元/股，成交量1.7394万股，换手率0.04%，振幅4.73%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817013147a1d4b19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817013147a1d4b19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB","BK4007"],"gpt_icon":1},{"id":"2459420128","title":"In8Bio, Inc.盘中异动 大幅拉升6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420128","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420128?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:34","pubTimestamp":1723728846,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时34分，In8Bio, Inc.股票出现波动，股价快速上涨6.58%。截至发稿，该股报0.640美元/股，成交量8377股，换手率0.02%，振幅3.42%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408152134069f2dfdd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408152134069f2dfdd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2459517727","title":"In8Bio, Inc.盘中异动 急速跳水6.01%报0.610美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459517727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459517727?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:53","pubTimestamp":1723643608,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时53分，In8Bio, Inc.股票出现波动，股价快速下挫6.01%。截至发稿，该股报0.610美元/股，成交量3161股，换手率0.01%，振幅1.85%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215329ab5daf97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814215329ab5daf97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2458986981","title":"In8Bio, Inc.盘中异动 股价大跌5.57%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986981","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986981?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:37","pubTimestamp":1723469858,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时37分，In8Bio, Inc.股票出现波动，股价大幅下跌5.57%。截至发稿，该股报0.660美元/股，成交量87.3532万股，换手率1.98%，振幅3.10%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213738af9715e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213738af9715e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2458346726","title":"In8Bio, Inc.盘中异动 股价大跌5.09%报0.673美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458346726","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458346726?lang=zh_cn&edition=full","pubTime":"2024-08-08 23:57","pubTimestamp":1723132644,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日23时57分，In8Bio, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报0.673美元/股，成交量4.1929万股，换手率0.10%，振幅8.05%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.49%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235724aefdf37c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808235724aefdf37c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2457076228","title":"In8Bio, Inc.盘中异动 下午盘急速下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457076228","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457076228?lang=zh_cn&edition=full","pubTime":"2024-08-07 01:07","pubTimestamp":1722964035,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日01时07分，In8Bio, Inc.股票出现波动，股价大幅下跌5.33%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408070107159682468e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408070107159682468e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2456238581","title":"In8Bio, Inc.盘中异动 早盘股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456238581","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456238581?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:22","pubTimestamp":1722608536,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时22分，In8Bio, Inc.股票出现波动，股价大幅跳水5.58%。截至发稿，该股报0.803美元/股，成交量1.7533万股，换手率0.04%，振幅4.02%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.34%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222216941fd97d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222216941fd97d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2455907959","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455907959","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455907959?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:57","pubTimestamp":1722351463,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时57分，In8Bio, Inc.股票出现波动，股价急速上涨5.24%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225743af94de15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225743af94de15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2454340549","title":"In8Bio, Inc.盘中异动 早盘大幅上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454340549","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454340549?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:42","pubTimestamp":1722001321,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时42分，In8Bio, Inc.股票出现波动，股价大幅拉升5.44%。截至发稿，该股报0.857美元/股，成交量1298股，换手率0.00%，振幅5.44%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214201955d9980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214201955d9980&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2454804825","title":"In8Bio, Inc.盘中异动 大幅跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454804825","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454804825?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:39","pubTimestamp":1721925550,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时39分，In8Bio, Inc.股票出现波动，股价大幅跳水5.19%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726003911968205ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726003911968205ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2453713770","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453713770","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453713770?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:08","pubTimestamp":1721668126,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时08分，In8Bio, Inc.股票出现异动，股价快速拉升5.24%。截至发稿，该股报0.874美元/股，成交量4.5797万股，换手率0.10%，振幅3.98%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010847aefacdd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010847aefacdd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2450253340","title":"In8Bio, Inc.盘中异动 快速上涨6.86%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450253340","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450253340?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791086,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，In8Bio, Inc.股票出现异动，股价急速拉升6.86%。截至发稿，该股报0.898美元/股，成交量5839股，换手率0.01%，振幅0.87%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131269f3c00b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131269f3c00b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2448161179","title":"In8Bio, Inc.盘中异动 股价大跌5.92%报0.765美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448161179","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448161179?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:27","pubTimestamp":1719937643,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时27分，In8Bio, Inc.股票出现异动，股价快速跳水5.92%。截至发稿，该股报0.765美元/股，成交量9.5042万股，换手率0.22%，振幅9.59%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703002723af903757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703002723af903757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2448994668","title":"In8Bio, Inc.盘中异动 大幅下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448994668","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448994668?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:50","pubTimestamp":1719856236,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时50分，In8Bio, Inc.股票出现异动，股价快速下挫5.49%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702015036aef770fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702015036aef770fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2445077939","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445077939","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445077939?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:50","pubTimestamp":1719237056,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时50分，In8Bio, Inc.股票出现波动，股价快速上涨5.68%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215056941f0934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215056941f0934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2444217855","title":"In8Bio, Inc.盘中异动 快速跳水5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217855","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444217855?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:46","pubTimestamp":1718891206,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时46分，In8Bio, Inc.股票出现异动，股价快速下挫5.00%。截至发稿，该股报0.950美元/股，成交量12.1197万股，换手率0.27%，振幅2.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214646aef5dac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214646aef5dac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2444160420","title":"In8Bio, Inc.盘中异动 快速拉升5.05%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444160420","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444160420?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:36","pubTimestamp":1718631411,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时36分，In8Bio, Inc.股票出现波动，股价快速拉升5.05%。截至发稿，该股报1.15美元/股，成交量17.5077万股，换手率0.40%，振幅2.75%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721365296814a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721365296814a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":-0.2357},{"period":"1month","weight":-0.3676},{"period":"3month","weight":-0.4703},{"period":"6month","weight":-0.4386},{"period":"1year","weight":-0.4755},{"period":"ytd","weight":-0.6123}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于通过使用同种异体、自体和基因修饰的γ-δT细胞。γ-δT细胞是人体免疫系统中自然产生的细胞，它识别并杀死癌细胞，同时具有保护健康组织的肿瘤识别机制。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.098793},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.077829},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098136},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.097265},{"month":5,"riseRate":0.666667,"avgChangeRate":0.389911},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.253166},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.039223},{"month":8,"riseRate":0.25,"avgChangeRate":-0.193376},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.074083},{"month":10,"riseRate":0.333333,"avgChangeRate":0.005196},{"month":11,"riseRate":0,"avgChangeRate":-0.162866},{"month":12,"riseRate":0.666667,"avgChangeRate":0.246461}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}